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Peritoneal dialysis (PD) is an established mode of renal replacement therapy, based on the exchange of fluid and solutes between blood in
peritoneal capillaries and a dialysate that has been introduced in the peritoneal cavity. The dialysis involves diffusive and convective transports and
osmosis through the highly vascularized peritoneal membrane. Computer simulations predicted that the membrane contains ultrasmall pores
(radius < 3 Å) responsible for the transport of solute-free water across the capillary endothelium during crystalloid osmosis. The distribution of the
water channel aquaporin-1 (AQP1), as well as its molecular structure ensuring an exquisite selectivity for water perfectly fit with the
characteristics of the ultrasmall pore. Treatment with corticosteroids induces the expression of AQP1 in peritoneal capillaries and increases water
permeability and ultrafiltration in rats, without affecting the osmotic gradient and the permeability for small solutes. Studies in knockout mice
provided further evidence that osmotically-driven water transport across the peritoneal membrane is mediated by AQP1. AQP1 and endothelial
NO synthase (eNOS) show a distinct regulation within the endothelium lining peritoneal capillaries. In acute peritonitis, the upregulation of eNOS
and increased release of NO dissipate the osmotic gradient and result in ultrafiltration failure, despite the unchanged expression of AQP1. These
data illustrate the potential of the peritoneal membrane to investigate the role and regulation of AQP1 in the endothelium. They also emphasize the
critical role of AQP1 during peritoneal dialysis and suggest that manipulating AQP1 expression may be used to increase water permeability across
the peritoneal membrane.
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Renal replacement therapy represents a major health issue. In
2001, more than 1 million patients with end-stage renal disease
(ESRD) were on dialysis worldwide, and that number is
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dialysis (PD) has become an established treatment for ESRD,
accounting for about 15% of the total number of patients on
dialysis worldwide [2]. Recent insights in the physiology and
pathophysiology of the peritoneal membrane, as well as
technical advances have improved the popularity of PD [3].
Like any dialysis technique, the aim of PD is to remove the
excess of water and uremic toxins from the blood of patients with
ESRD. To perform PD, a catheter is implanted in the peritoneal
cavity, and a solution (called “the dialysate”) that contains phy-
siologic concentrations of sodium, chloride, calcium, magne-
sium, and a buffer (lactate or bicarbonate) is infused through it.
The dialysate remains in the peritoneal cavity for some hours and
is then drained out before fresh dialysate is reinfused. Dialysis
occurs during the stagnation time, when solutes and water move
between the blood and the dialysate through the peritoneal mem-
brane. The peritoneal membrane consists of three main anato-
mical components: the capillary wall, the interstitium (primarily
composed by a mucopolysaccharide matrix and bundles of col-
lagen fibers), and the mesothelium (Fig. 1, panel A). Solutes
diffuse between blood and dialysate by diffusive and convective
transports, according to their concentration gradient. Ultrafiltra-
tion (UF), i.e., the amount of water removed from the patient,
depends from the presence of an osmotic agent (most often glu-
cose) in the dialysate. Low-molecular weight solutes, such as
urea and creatinine, accompany water movements [3].Fig. 1. Structure of the peritoneal membrane and expression and distribution of AQP
The peritoneal membrane contains three components: a layer of ciliated meso
mucopolysaccharides; a dense network of capillaries, blood vessels, and lymphatics.
small veins. (Scale bar: 40 μm). (Panel B) Immunogold electron microscopy on mous
plasma membrane and plasma membrane infoldings of capillary endothelial cells.
endothelial cells than in red blood cells (rbc). (Bar: 500 nm). (Panel C) Immunoblotti
and glycosylated isoforms of AQP1 are identified, as well as eNOS (140 kDa) andThe parameters influencing the transport of solutes and
water across the peritoneal membrane during PD are i) the
exchange frequency and volume of the dialysate; ii) the
osmolality of the dialysate; (iii) the peritoneal blood flow; iv)
the amount of perfused peritoneal capillaries (« effective
peritoneal vascular surface area, EPSA »); and v) the
microvascular intrinsic permea-bility [4]. The main transport
parameters across the peritoneal membrane are routinely
evaluated using the peritoneal equilibration test (PET),
which is based on the rate of small solutes transport during
an exchange [2]. According to these basic principles, any
increase in the transport of small solutes across the membrane
will cause a rapid dissipation of the osmotic gradient (due to
increased reabsorption of glucose, the osmotic agent, from the
dialysate) and a loss of UF, causing fluid overload in the
uremic patient. Accordingly, the capacity of osmotically-
induced UF across the peritoneal membrane is a major
predictor of outcome and mortality in PD patients [5]. Failure
of this UF capacity is the most frequent abnormality in long-
term PD patients, and the main reason for technical failure [6].
2. The capillary endothelium in the PM contains ultrasmall
pores selective for water
The exchange of fluid across the peritoneal membrane during
PD is best explained by a “three-pore” model based upon1. (Panel A) Cross-section of the human parietal peritoneum stained for AQP1.
thelial cells (m); the interstitial tissue containing bundles of collagen and
AQP1 is detected in the endothelium lining peritoneal capillaries, venules, and
e visceral peritoneum unicryl sections shows a very strong signal for AQP1 in the
Note (right panel) that the density of AQP1 labeling is markedly stronger in
ng of AQP1 and endothelial markers in the mouse visceral peritoneum. The core
caveolin-1 (20 kDa) in the same samples (20 μg protein/lane).
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transport barrier of the PM is the capillary endothelium, which
contains three distinct types of pores [8]. The “small pores”
(radius 40 to 50 Å) correspond to the clefts located between
endothelial cells. They account for ∼95% of the hydraulic con-
ductance (UF coefficient, LpS), i.e., the vast majority of the total
pore surface area available for the diffusion of small solutes
including urea, creatinine, and glucose. A second population of
pores, the “large pores” (radius 250 Å), thought to correspond to
the venular interendothelial gaps, accounts for 5% of the UF
coefficient. These pores are involved in the transport of macro-
molecules (proteins, immunoglobulins) and, although they rep-
resent only 0.01% of the total number of pores, they mediate an
important part of the UF via convection of plasma from blood to
the peritoneal cavity. The third population of pores consists in
water-specific, “ultrasmall pores” located in the endothelial
cells. The ultrasmall pores account only for 1–2% of the hy-
draulic conductance, meaning an almost insignificant contribu-
tion to the overall UF coefficient. However, because they reject
solutes but facilitate the transport of water, the ultrasmall pores
are extremely important during crystalloid osmosis. Thus, they
have been predicted to mediate half of the UF, as well as the
“sodium sieving”, i.e., the fall in dialysate sodium concentration
caused by a rapid transport of water from the blood into the
peritoneal cavity during a dwell with hypertonic glucose [7,8]Fig. 2. Influence of corticosteroid treatment on sodium sieving, net ultrafiltration, and
the visceral peritoneum of rats treated with saline (sham) or dexamethasone (1 mg/k
visualized with goat anti-rabbit IgG conjugated to 10-nm colloidal gold particles. AQP
(e) lining peritoneal capillaries. The abundance of AQP1 in endothelial cells is mark
Results of the peritoneal equilibration test (PET) performed after 5 days of treatment w
4 mg). The dialysate-to-plasma (D/P) ratios of sodium in sham (□), Dexa 1 mg (▪)The drop in the D/P sodium at 30 min of the dwell (“sodium sieving”) is classically us
capillary endothelium (the latter correspond actually to AQP1, see text). Treatment wi
which can be interpreted as an increase in AQP1-mediated water transport, and a sig
*P<0.05 Dexa 1 mg/kg vs. sham; there were 6 rats in each group. (Modified from(see Fig. 2, panel B). Understanding the molecular counterpart
and the role of the ultrasmall pores has a major clinical impor-
tance, since the link between the integrity of the ultrasmall pores
and the UF capacity and sodium sieving remains a much debated
question in PD [9,10]. According to the three-pore model, the
ultrasmall pore should be located in the endothelium lining
peritoneal capillaries and post-capillary venules, where most of
the water movement during PD occurs [11]. It should also faci-
litate the water movement while being unpermeable to osmotic
agents such as glucose and glycerol, hence have a minimal
radius <3 Å [7,8].
3. Aquaporin-1 is the molecular counterpart of the
ultrasmall pore
The identification of the aquaporins, a family of integral
plasma membrane proteins conserved in bacteria, plants, and
mammals, provided critical insights in the molecular mechan-
isms involved in water permeation across biological membranes
[12]. The first identified member of the aquaporin (AQP) family
was aquaporin-1 (AQP1), a 28-kDa protein abundantly ex-
pressed in the membrane of human red blood cells [13]. To date,
11 members of the AQP family have been identified in mam-
mals, with specific expression patterns and distinct roles in given
tissues and cells. Most AQPs are exclusively permeable to water,AQP1 expression in the capillary endothelium. (Panel A) Ultrathin sections from
g) for 5 days were incubated with an affinity-purified anti-AQP1 antibody and
1 labeling is seen in both apical and basal plasma membranes of endothelial cells
edly increased in dexamethasone-treated animals. (Bar: 250 nm). (Panels B–C)
ith saline (sham) or dexamethasone at 1 mg/kg (Dexa 1 mg) or at 4 mg/kg (Dexa
and Dexa 4 mg (▾) during a 2-h dwell with 3.86% glucose dialysate are shown.
ed as an index of the free water transport across the ultrasmall pores present in the
th high-dose dexamethasone induces a significant increase in the sodium sieving,
nificant increase in net ultrafiltration (net UF) across the peritoneal membrane.
Ref. [26]).
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called “aquaglyceroporins”) transport water, glycerol, and urea
[14]. In addition to its abundant expression in proximal con-
voluted tubules and descending thin limbs of Henle's loop of the
mammalian kidney, AQP1 is located in the apical and basolateral
membranes of endothelial cells lining non-fenestrated capillaries
in a variety of tissues [15] including the peritoneum [16]. Studies
in human and rodent peritoneal membrane have confirmed that
AQP1 is abundantly expressed the endothelial cells lining capil-
laries, venules and small veins (Fig. 1), whereas it is not detected
in small-size arteries [17,18].
Several lines of evidence support the hypothesis that AQP1 is
the molecular counterpart of the ultrasmall pore of the PM.
The distribution of AQP1 in the endothelium lining
peritoneal capillaries is consistent with the predicted topology
of the ultrasmall pore (Fig. 1). The continuous endothelium
lining peritoneal capillaries is the most important barrier for
solute transport during PD; within that structure, the ultrasmall
pore must be transcellular, i.e., an integral plasma membrane
protein [7,8]. In addition, peritoneal capillaries and post-
capillary venules represent the principal location for solute
and fluid exchange during PD [11].
By principle, the ultrasmall pore is a water-only pathway that
reject small solutes such as urea and glucose. The structure of the
pore should thus account for the effectiveness of glucose (and
glycerol) as an osmotic agent in PD, hence have aminimal radius
<3 Å. Expression studies in oocytes of Xenopus laevis have
demonstrated that AQP1 is indeed a water-specific channel that
can be inhibited by mercurials [19]. These results were
confirmed by reconstitution of purified AQP1 within proteoli-
posomes, which also showed that AQP1 is not permeable to urea
and glycerol [20,21].
Structural informations about the pore formed by AQP1,
based on an atomic model at 3.8 Å resolution obtained by
electron cryomicroscopy [22], perfectly fit the postulated size of
the ultrasmall pore of the PM. AQP1 is a homotetramer, with
each monomer containing six tilted, membrane-spanning a-
helices surrounding a single central pore. The selectivity of the
pore for water (against protons) is ensured by several elements,
including a narrow constriction of 2.8 Å (which allows to
accommodate a single water molecule); a conserved arginine
residue lining the pore and providing a fixed positive charge that
creates electrostatic repulsion for protons; a transient reorienta-
tion of the water dipole resulting from the simultaneous forma-
tion of hydrogen bonding with the side chains of two conserved
asparagine residues (NPA motifs); and two partial positive
charges at the center of the channel resulting from two non-
membrane-spanning α helices [12]. Of interest is the location of
the side chain of a cysteine residue (Cys189) in the AQP1 pore,
explaining why the water permeability of many AQPs can be
inhibited by mercury compounds [22]. Yet, functional studies
conducted in rats and rabbits have shown that peritoneal water
permeability is significantly inhibited by HgCl2 under specific
experimental conditions (short-term tissue fixation) [16,23].
The promoter of the mouse Aqp1 gene is known to contain
glucocorticoid response elements (GREs) [24], and there is evi-
dence f orAQP1 induction by corticosteroids in perinatal rat lung[25]. Recently, we showed that glucocorticoid receptors are ex-
pressed in the peritoneal membrane, and that treatment of rats
with high doses of corticosteroids (dexamethasone, 1 to 4 mg/kg
daily) is associated with an increased expression of AQP1 in the
capillary endothelium, reflected by a significant increase in the
sodium sieving and net UF across the membrane (Fig. 2) [26].
These modifications of water transport were observed in absence
of any effect on the osmotic gradient, providing a strong argu-
ment for the role of AQP1 during PD [26]. These data also
suggested that pharmacoregulation of AQP1 could provide a
target for increasing UF in PD patients, which is clinically rele-
vant when considering that these patients are often overhydrated
[5,6].
Finally, the availability of knockout mice allowed to demon-
strate that osmotically-driven water transport across the PM
(estimated by the dilution of a tracer) is significantly decreased in
AQP1knockout (Aqp1−/−)mice,whereas it remainsunchangedin
Aqp4−/−mice [27]. Using a PET that has been well-characterized
in mouse [28], we recently showed that, in comparison with
Aqp1+/+ littermates, Aqp1−/− mice had no sodium sieving; a
∼70%decrease in the initial, solute-freeUF;anda∼50%decrease
in cumulative UF [29] (Fig. 3). These modifications occurred
despite unchangedosmotic gradient and transport of small solutes
in the Aqp1−/− mice. Furthermore, heterozygous Aqp1+/− mice
showed intermediate values in sodium sieving and initial UF. The
deletion of AQP1 had no effect on the structure of the peritoneal
membrane, in particular, the density or diameter of peritoneal
capillaries.Thesedataprovided thedefinitiveproof for thecritical
role of AQP1 during PD. They also validated essential predictions
of the three-pore model: (i) the ultrasmall pores account for the
sodium sieving; and (ii) they mediate 50% of UF during a
hypertonic dwell (Fig. 3).
4. Other aquaporins in the peritoneum
We recently used quantitative real-time RT-PCR to document
the expression patterns of the AQP gene family (AQP0 to
AQP10) in the mouse visceral peritoneum [29]. AQP1 was the
most abundant isoform, and the only one located in the capillary
endothelium. A significant expression of AQP7 (approximately
2-fold less thanAQP1) as well as low levels of AQP9 andAQP5,
and traces of AQP3 were also detected [29]. Staining for AQP1
and AQP3 has been inconsistently observed in rat and human
mesothelium [16,30]. Recent studies have demonstrated that the
expression of AQP1 in mesothelial cells, which may be too low
at baseline to be detected by immunostaining, is induced by
exposure to osmotic agents such as glucose and mannitol
[30,31]. This induction probably reflects the presence of hyper-
tonicity response elements in the AQP1 promoter [32]. Because
the mesothelium does not represent a significant functional
barrier for water transport in PD, the functional importance of
AQPs at that level remains unclear. The water channel could
participate in the volume regulation of these cells, which are
known to undergo rapid change in volume when exposed to
hypertonic dialysates used in PD.
Could aquaporins other than AQP1 play a role in the water
permeability of the peritoneal membrane? The only aquaporin
Fig. 3. Effect of AQP1 deletion on the transport of water and small solutes across the peritoneal membrane. Mice with a targeted deletion of Aqp1 were investigated
using a peritoneal equilibration test essentially similar to that performed in patients. The dialysate-to-plasma (D/P) ratio of sodium (panel A), the progressive removal
of glucose from the dialysate (D/D0 glucose, panel B), and the initial ultrafiltration rates (solute-free water transport, panel C) were determined in Aqp1+/+mice (black
squares), Aqp1+/−mice (green triangles), and Aqp1−/−mice (pink circles) during a 2-h exchange with 2 ml of 7% glucose dialysate. In comparison with Aqp1+/+ mice,
mice lacking AQP1 show a complete loss of sodium sieving, whereas the glucose reabsorption from dialysate is unchanged. Aqp1−/− mice also show significantly
lower initial UF rates. Intermediate values of sodium sieving and initial UF rates are observed in Aqp1+/−mice. *P<0.05 vs. Aqp1+/+mice; #P<0.05 vs. Aqp1+/−mice.
(Modified from Ref. [29]).
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of the peritoneum is AQP1 [16–18,27–29]. The vasopressin-
sensitivity of AQP2, as well as the HgCl2-insensitivity of
AQP4 render unlikely their participation in the water
permeability of the peritoneum [17,27]. Using well-character-
ized antibodies, we and others were unable to document any
expression of AQP3 and AQP4 in the capillary endothelium of
rat peritoneum [18,27]. The fact that glycerol is an effective
osmotic agent that can replace glucose in PD [33] argues
against a functional role of the aquaglyceroporins in water
transport during PD. By contrast, AQP7 could play an
important role in the adipocytes of the peritoneum, by acting
as a glycerol transporter [34,35].
5. Differential regulation of AQP1 and endothelial nitric
oxide synthase in the PM
A decrease in UF, either acute (such as in peritonitis) or
chronic (such as in long-term PD), is commonly observed in
patients treated by PD. The loss of UF has severe clinical
consequences, e.g., increased extracellular fluid volume, and is
associated with higher morbidity and mortality in PD patients
[5]. As mentioned earlier, AQP1 mediates up to 50% of the
UF during the PD procedure. An increased transport of smallsolutes, due to an increased effective peritoneal surface area, is
invariably associated with a higher reabsorption of glucose
and an early dissipation of the osmotic gradient, constituting
the most common cause of UF failure in PD [4–6]. In recent
studies, we investigated the potential contributions of AQP1
and endothelial nitric oxide synthase (eNOS) in these
modifications.
Nitric oxide (NO) regulates vascular tone and permeability
[36], and early experiments showed that the NO donor nitro-
prusside increases the effective peritoneal surface area and the
intrinsic permeability of the PM [37]. A specific NO synthase
(NOS) activity can be detected in the peritoneal membrane, in
relation with the expression of the three NOS isoforms—the
neuronal NOS (nNOS, NOS1), the inducible NOS (iNOS,
NOS2), and the endothelial NOS (eNOS, NOS3) [18,38]. In-
flammation of the peritoneum is associated with a marked
increase in total and Ca2+-dependent NOS activity, due to upre-
gulated eNOS expression, whereas AQP1 expression is un-
changed [17]. Although AQP1 and eNOS are both expressed in
the capillary endothelium, eNOS is located in the endothelium
lining all types of blood vessels including arterioles, whereas
AQP1 is restricted to capillaries, venules and small veins [17,18,
28]. The differential regulation of AQP1 and eNOS was further
illustrated in the detailed study of a long-term PD patient
1083O. Devuyst, J. Ni / Biochimica et Biophysica Acta 1758 (2006) 1078–1084characterized by UF failure due to abolition of transcellular water
permeability despite an apparently normal expression of AQP1
[39].
Further studies in rat and mouse models of acute peritonitis
allowed us to further investigate the role of AQP1 and eNOS
in the PM [18,40,41]. These studies revealed that the loss of
water permeability and UF in acute peritonitis is due to an
increased peritoneal transport for small solutes that appears to
be primarily mediated by the increased eNOS, without
quantitative nor qualitative evidence for a decrease in AQP1
expression. These data suggest that the release of NO in the
capillary endothelium is a major regulator of water perme-
ability across the PM, because it induces a vasodilation (and
thus increases the peritoneal exchange surface area and
dissipates the osmotic gradient) and promotes angiogenesis
[18,41]. However, the lack of total reversibility of the
permeability modifications following treatment with L-
NAME [40] or in eNOS knockout mice [41] suggests the
intriguing hypothesis that increased NO levels, secondary to
eNOS upregulation, could modify plasma membrane proteins
such as AQP1 and interfere with their functions in endothelial
cells [39,40]. Such interaction, probably favoured by the co-
localization of AQP1 and eNOS in caveolae [15,16], is also
suggested by the intense reactivity for nitro-tyrosine and
nitroso-cysteine observed in the capillary endothelium during
acute peritonitis [18,40].
6. Conclusions and perspectives
Transcellular water permeability mediated by AQP1 is an
essential component of the water removal from uremic patients
during PD. Several lines of evidence, culminating with studies in
AQP1 knockout mice, have demonstrated that AQP1 is the
ultrasmall pore that was predicted by the three-pore model based
on computer simulations [7]. This molecular pathway is
responsible for ∼50% of the UF during PD, and has thus a
major clinical relevance for patients treated by PD. The fact that
the expression of AQP1 in the PM can be modulated by
corticosteroids opens new perspectives for treating UF failure in
some PD patients. Furthermore, the peritoneal membrane could
represent a useful model to investigate the complex relationships
between AQP1, eNOS, and other relevant molecules in the
endothelium, and to assess their influence on water transport and
angiogenesis [42]. The strict correlation between AQP1
abundance and solute-free water transport across the membrane,
that was recently demonstrated using the AQP1mouse [29], may
also be useful for in vivo investigations of drugs targeting the
channel.
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